📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment. (2018)

First Author: Sliz E

Attributed to: Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/circulationaha.118.034942

PubMed Identifier: 30524137

Publication URI: http://europepmc.org/abstract/MED/30524137

Type: Journal Article/Review

Volume: 138

Parent Publication: Circulation

Issue: 22

ISSN: 0009-7322